Intervention Review

Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent disease

  1. Albiruni Ryan Abdul Razak1,*,
  2. Louise Li2,
  3. Andrew Bryant3,
  4. Ivan Diaz-Padilla1

Editorial Group: Cochrane Gynaecological Cancer Group

Published Online: 16 MAR 2011

Assessed as up-to-date: 9 FEB 2011

DOI: 10.1002/14651858.CD007584.pub2

Database Title

Additional Information

How to Cite

Abdul Razak AR, Li L, Bryant A, Diaz-Padilla I. Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent disease. Cochrane Database of Systematic Reviews 2011, Issue 3. Art. No.: CD007584. DOI: 10.1002/14651858.CD007584.pub2.

Author Information

  1. 1

    Princess Margaret Hospital, Department of Medical Oncology, Toronto, ON, Canada

  2. 2

    Northern Centre for Cancer Treatment, Medical Oncology Department, Newcastle upon Tyne, UK

  3. 3

    Newcastle University, Institute of Health and Society, Newcastle upon Tyne, UK

*Albiruni Ryan Abdul Razak, Department of Medical Oncology, Princess Margaret Hospital, 610 University Avenue, Toronto, ON, M5G 2M9, Canada. albiruni_ryan@yahoo.co.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 16 MAR 2011

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (60K)Standard (262K)Full (275K)

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via Athens http://onlinelibrary.wiley.com/athens or other institutional login options http://onlinelibrary.wiley.com/login-options .
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

View Full Article (HTML) Summary (60K)Standard (262K)Full (275K)